Sandeep Bandu Khandagale

Title: Innovations of Sandeep Bandu Khandagale

Introduction

Sandeep Bandu Khandagale is a notable inventor based in Thane, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes and compounds. With a total of four patents to his name, Khandagale has demonstrated a strong commitment to advancing medical science.

Latest Patents

Khandagale's latest patents include a process for the preparation of apremilast, which relates to a method for synthesizing this important pharmaceutical compound. Additionally, he has developed a p-xylene solvate of apremilast and a process for its preparation. Another significant patent involves polymorphs of a mPGES-1 inhibiting triazolone compound, which showcases solid-state forms of a triazolone compound that exhibit mPGES-1 enzyme inhibition activity. This compound, specifically N-(4-chloro-3-(5-oxo-1-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-3-yl)benzyl)pivalamide, represents a promising advancement in pharmaceutical research.

Career Highlights

Throughout his career, Khandagale has worked with prominent companies in the pharmaceutical industry, including Glenmark Pharmaceuticals S.A. and Glenmark Life Sciences Limited. His work in these organizations has allowed him to contribute to the development of innovative pharmaceutical solutions.

Collaborations

Khandagale has collaborated with several professionals in his field, including Suresh Mahadev Kadam and Sachin Baban Gavhane. These collaborations have further enhanced his research and development efforts.

Conclusion

Sandeep Bandu Khandagale is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His innovative patents and collaborations reflect his dedication to advancing medical science and improving patient outcomes.